Table 3.
Antiretroviral Treatment Prescription in Naïve Patients by Years.
| Variables (%) | 2009-2010 (n = 99) | 2011-2012 (n = 112) | 2013-2014 (n = 135) | 2015-2016 (n = 146) |
|---|---|---|---|---|
| Backbone | ||||
| TDF/FTC | 86.9 | 92.0 | 82.2 | 62.8 |
| ABC/3TC | 5.1 | 6.2 | 17.1 | 17.9 |
| 3TC/AZT | 7.1 | 1.8 | 0.7 | 0.0 |
| TAF/FTC | 0.0 | 0.0 | 0.0 | 19.3 |
| PI | 60.8 | 42.7 | 53.6 | 16.3 |
| NNRTI | 37.0 | 49.4 | 39.3 | 12.6 |
| INSTI | 2.2 | 7.9 | 7.1 | 71.1 |
Abbreviations: ABC/3TC, abacavir/lamivudine; INSTI, integrase strand transfer inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitor; TAF/FTC, tenofovir alafenamide fumarate/emtricitabine; TDF/FTC, tenofovir disoproxil fumarate/emtricitabine; 3TC/AZT, lamivudine/zidovudine.